Method of using lanthionine synthetase component C-like proteins as molecular targets for preventing and treating diseases and disorders.

Bassaganya-Riera, J., P. Lu, and R. Hontecillas

(10-116 VTIP) Provisional Patent Application No: 61/331,086; U.S. Patent Application No. 13/100,795